TOP HEADLINES

Hospitalists: Two-midnight rule has negative impact on patient care, finances

Add hospitalists to the growing list of medical professionals who are concerned about the federal government requirements for short inpatient stays.

Physicians and business-oriented bosses clash over healthcare

As the face of hospital and health system leadership changes to those who aren't necessarily from a healthcare background, tensions between doctors and their business school managers are on the rise and patients could suffer, according to a Bloomberg Businessweek article.

20 arrested during union rally at UPMC

At least 20 protesters were arrested Wednesday during a Service Employees International Union-organized demonstration in front of University of Pittsburgh Medical Center headquarters, according to the Pittsburgh Post-Gazette.

Health leaders balk at IOM recommendations

Following the release of an Institute of Medicine report that proposes sweeping changes in how graduate medical education is funded, teaching hospital leaders worry about the proposal's implications, Hospitals & Health Networks Daily reports.

VA audit: Many employees manipulated data under supervisors' orders

An audit released this week by the Department of Veterans Affairs healthcare system uncovered even more cases of fraud, data manipulation and staff intimidation to cover up extreme delays in care.

MORE NEWS

From Our Sister Sites

FierceHealthPayer

As a way of paying for quality rather than volume, many  insurers are moving away from a fee-for-service payment model toward a value-based reimbursement process that focuses more on transparency and accountability,  FierceHealthPayer  previously reported. To better understand the benefits of a value-based payment model operates, spoke with California-based Kaiser Permanente's Jack Cochran (pictured), M.D., FACS,  executive director of the Permanente Federation in an exclusive interview.

FierceMobileHealthcare

The U.S. Food and Drug Administration on Friday released draft guidance on a wide ranging list of medical devices--many of which fall into the mobile healthcare spectrum--which the agency believes do not require premarket notification review for safety and effectiveness.